Medpace Holdings, Inc.
MEDP
Key stats
- Open
- 658.92
- Day high
- 662.50
- Day low
- 648.35
- Previous close
- 664.77
- Volume
- 142.2K
- VWAP
- 656.35
- 52-week high
- 693.97
- 52-week low
- 373.00
- Market cap
- 18.59B
- Shares out
- 27.97M
- Employees
- 6,600
- Listed
- 2016
About Medpace Holdings, Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH · CINCINNATI, OH · medpace.com
Options · expiring Nov 20
Nov 12, 4:00 PM ET- Call open interest
- 669
- Put open interest
- 659
- Put/call
- 0.99
- At-the-money IV
- 36.0%
| Contract | Last | Traded | Volume | Open int. | IV |
|---|---|---|---|---|---|
| 700 put | 86.30 | Oct 20, 9:30 AM | 16 | 16 | 36.1% |
| 620 call | 69.60 | Oct 21, 3:45 PM | 6 | 5 | 40.1% |
| 590 put | 5.05 | Nov 2, 9:47 AM | 5 | 205 | 56.9% |
| 680 put | 20.00 | Oct 29, 2:30 PM | 5 | 6 | 35.0% |
| 610 put | 2.08 | Nov 11, 3:52 PM | 4 | 7 | 48.8% |
| 580 call | 96.80 | Oct 21, 3:45 PM | 3 | 3 | 44.6% |
Quarterly results
Massive · Oct 22, 2026| Q3 2026 to Sep 30, 2026 | Q2 2026 to Jun 30, 2026 | Q1 2026 to Mar 31, 2026 | Q4 2025 to Dec 31, 2025 | |
|---|---|---|---|---|
| Revenue | $716.00M | $707.33M | $706.60M | $708.45M |
| Gross profit | $223.88M | $201.64M | $196.33M | $205.32M |
| Operating income | $165.54M | $146.82M | $141.50M | $153.27M |
| Net income | $137.46M | $121.36M | $123.87M | $135.13M |
| Diluted EPS | 4.84 | 4.25 | 4.28 | 4.67 |
| Operating cash flow | $216.60M | $162.01M | $151.79M | $192.65M |
| Assets | $2.30B | $2.06B | $2.13B | $1.98B |
| Liabilities | $1.72B | $1.62B | $1.53B | $1.52B |
| Equity | $584.94M | $433.86M | $598.31M | $459.07M |
Technicals
Massive · Nov 12, 2026- 50-day average628.31
- 200-day average531.71
- RSI (14 days)53.0
Short interest
Massive · Oct 30, 2026- Oct 30, 20261.38M shares · 3.5 days to cover
- Oct 15, 20261.61M shares · 6.6 days to cover
- Sep 30, 20261.60M shares · 5.8 days to cover
- Sep 15, 20261.69M shares · 8.8 days to cover
Related companies
MassiveNews coverage
No stories about Medpace Holdings, Inc. right now.